Aripiprazole Oral Acceptability Trial

NCT00101569 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Aripiprazole
DRUG: Aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]